0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 41-60 of 913 Articles
JAMA Dermatology | 
Editorial | 
Albert Rübben, MD; Ralf-Dieter Hilgers, PhD; Martin Leverkus, MD
JAMA Dermatol. 2016;152(5):521-523. doi:10.1001/jamadermatol.2015.5239.

JAMA Dermatology | 
Original Investigation | 
Shalini V. Mohan, MD; Julia Chang, BS; Shufeng Li, MS; et al.
JAMA Dermatol. 2016;152(5):527-532. doi:10.1001/jamadermatol.2015.4330.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. 2016;2(5):625-632. doi:10.1001/jamaoncol.2015.5932.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. 2016;2(5):655-662. doi:10.1001/jamaoncol.2015.5392.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Mariam B. Totonchy, MD; Harib H. Ezaldein, BS; Christine J. Ko, MD; et al.
JAMA Dermatol. 2016;152(5):590-592. doi:10.1001/jamadermatol.2015.5210.

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncol. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0264
Includes: Supplemental Content

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0350

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Oncol. Published online April 21, 2016. doi:10.1001/jamaoncol.2016.0429
Includes: Supplemental Content

JAMA Dermatology | 
Original Investigation |  ONLINE FIRST
Audrey A. Jacobsen, BA; Adam S. Aldahan, BS; Olivia B. Hughes, BS; et al.
JAMA Dermatol. Published online April 20, 2016. doi:10.1001/jamadermatol.2016.0780

JAMA | 
Editorial | 
David D. Waters, MD; Priscilla Y. Hsue, MD; Sripal Bangalore, MD, MHA
JAMA. 2016;315(15):1571-1572. doi:10.1001/jama.2016.3670.

JAMA | 
Original Investigation | 
Steven E. Nissen, MD; Erik Stroes, MD, PhD; Ricardo E. Dent-Acosta, MD; et al.
JAMA. 2016;315(15):1580-1590. doi:10.1001/jama.2016.3608.
Includes: CME, Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
Mark D. Pegram, MD
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0238

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ahmad Awada, MD, PhD; Ramon Colomer, MD, PhD; Kenichi Inoue, MD; et al.
JAMA Oncol. Published online April 14, 2016. doi:10.1001/jamaoncol.2016.0237
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Loes Jaspers, MD; Frederik Feys, MSc, PhD; Wichor M. Bramer, BSc; et al.
JAMA Intern Med. 2016;176(4):453-462. doi:10.1001/jamainternmed.2015.8565.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2016;176(4):482-483. doi:10.1001/jamainternmed.2015.8597.

JAMA Internal Medicine | 
Original Investigation | 
Dima M. Qato, PharmD, MPH, PhD; Jocelyn Wilder, MPH; L. Philip Schumm, MA; et al.
JAMA Intern Med. 2016;176(4):473-482. doi:10.1001/jamainternmed.2015.8581.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
News From the Food and Drug Administration  | 
New Fluoroquinolone Warning
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Internal Medicine
Invited Commentary  | 
Habitual Prescribing of Laxatives—It’s Time to Flush Outdated Protocols Down the Drain
Kanako Y. McKee, MD; Eric Widera, MD